Literature DB >> 10808164

Atopic dermatitis: new insights and opportunities for therapeutic intervention.

D Y Leung1.   

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease that frequently predates the development of allergic rhinitis or asthma. It is an important skin condition with significant costs and morbidity to patients and their families; the disease affects more than 10% of children. Recent studies have demonstrated the complex interrelationship of genetic, environmental, skin barrier, pharmacologic, psychologic, and immunologic factors that contribute to the development and severity of AD. The current review will examine the cellular and molecular mechanisms that contribute to AD as well as the immunologic triggers involved in its pathogenesis. These insights provide new opportunities for therapeutic intervention in this common skin condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10808164     DOI: 10.1067/mai.2000.106484

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  98 in total

1.  T cells and effector mechanisms in the pathogenesis of atopic dermatitis.

Authors:  Mübeccel Akdis; Axel Trautmann; Kurt Blaser; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

2.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 3.  What is the 'true' function of skin?

Authors:  C M Chuong; B J Nickoloff; P M Elias; L A Goldsmith; E Macher; P A Maderson; J P Sundberg; H Tagami; P M Plonka; K Thestrup-Pederson; B A Bernard; J M Schröder; P Dotto; C M Chang; M L Williams; K R Feingold; L E King; A M Kligman; J L Rees; E Christophers
Journal:  Exp Dermatol       Date:  2002-04       Impact factor: 3.960

Review 4.  [Atopic eczema. Spectrum of provocation factors and possibilities for their effective reduction and elimination].

Authors:  S Fischer; J Ring; D Abeck
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

Review 5.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

6.  Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.

Authors:  T Hofman; N Cranswick; P Kuna; A Boznanski; T Latos; M Gold; D F Murrell; K Gebauer; U Behre; E Machura; J Olafsson; Z Szalai
Journal:  Arch Dis Child       Date:  2006-06-23       Impact factor: 3.791

7.  Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge.

Authors:  Rui He; Michiko K Oyoshi; Haoli Jin; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

8.  IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice.

Authors:  Haoli Jin; Michiko K Oyoshi; Yi Le; Teresa Bianchi; Suresh Koduru; Clinton B Mathias; Lalit Kumar; Séverine Le Bras; Deborah Young; Mary Collins; Michael J Grusby; Joerg Wenzel; Thomas Bieber; Marianne Boes; Leslie E Silberstein; Hans C Oettgen; Raif S Geha
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

9.  BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites.

Authors:  Aurea Welter; José Roberto Mineo; Deise Aparecida de Oliveira Silva; Elaine Vicente Lourenço; Eloísa Amália Vieira Ferro; Maria Cristina Roque-Barreira; Neide Maria da Silva
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

10.  Allergies in children.

Authors:  Z Chad
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.